The study confirms endothelial dysfunction in OSA patients as indicated by increased serum levels of ET-1 and possibly endothelial dysfunction in diabetic OSA patients as indicated by increased serum levels of LOX-1 and their correlation with fasting glucose levels. The gene discussed is OLR1; the disease is obstructive sleep apnea syndrome.